Neonatal screening for biotinidase deficiency in north eastern italy

1988 ◽  
Vol 147 (3) ◽  
pp. 317-318 ◽  
Author(s):  
A. B. Burlina ◽  
W. G. Sherwood ◽  
M. V. Marchioro ◽  
B. Dalla Bernardina ◽  
D. Gaburro

2005 ◽  
Vol 63 (4) ◽  
pp. 180-186 ◽  
Author(s):  
Paolo Cavarzere ◽  
Marta Camilot ◽  
Francesca Teofoli ◽  
Luciano Tatò




Author(s):  
B. Wolf ◽  
G. S. Heard ◽  
L. G. Jefferson ◽  
K. A. Weissbecker ◽  
J. R. Secor McVoy ◽  
...  


1984 ◽  
Vol 30 (1) ◽  
pp. 125-127 ◽  
Author(s):  
G S Heard ◽  
J R Secor McVoy ◽  
B Wolf

Abstract We describe a method for neonatal screening for biotinidase (EC 3.5.1.12) deficiency. Biotinidase activity is assessed colorimetrically from dried samples of whole blood spotted on the same filter papers as used in the neonatal screening for phenylketonuria. After the reaction, samples from normal infants are characteristically purple, whereas those from affected individuals are straw-colored. To confirm the deficiency, the enzyme is quantitatively assayed in additional blood spots or serum. A pilot study has been initiated with samples obtained by the Commonwealth of Virginia for phenylketonuria testing.



2017 ◽  
Vol 13 ◽  
pp. 80-82 ◽  
Author(s):  
Francesco Porta ◽  
Veronica Pagliardini ◽  
Isabella Celestino ◽  
Enza Pavanello ◽  
Severo Pagliardini ◽  
...  


1985 ◽  
Vol 19 (4) ◽  
pp. 256A-256A ◽  
Author(s):  
Barry Wolf ◽  
Gregory S Heard ◽  
Linda G Jefferson ◽  
Walter E Nance ◽  
Karen A Weissbecker


2014 ◽  
Vol 24 (3) ◽  
Author(s):  
Marilis Tissot Lara ◽  
Marcos José Burle de Aguiar ◽  
Juliana Gurgel Giannetti ◽  
José Nélio Januári


2016 ◽  
Vol 175 (5) ◽  
pp. 395-402 ◽  
Author(s):  
Paolo Cavarzere ◽  
Marta Camilot ◽  
Florina Ion Popa ◽  
Silvana Lauriola ◽  
Francesca Teofoli ◽  
...  

Objective To evaluate the incidence of congenital hypothyroidism (CH) with delayed TSH elevation among low-birth-weight (LBW) newborns in North-Eastern Italy and to verify if they need a second or third screening. Design Analysis of clinical and biochemical data of newborns affected by CH with delayed TSH elevation identified by neonatal screening. Methods Data of all newborns with birth weight (BW) <2500 g and evidence of delayed TSH elevation at newborn screening were collected between 2011 and 2014. Confirmatory tests were based on serum TSH and FT4 levels. All their clinical signs at diagnosis were reported. Results 57.5% of LBW newborns with delayed TSH increase at neonatal screening presented a CH with delayed TSH elevation and began a treatment with l-thyroxine. The incidence of this condition in North-Eastern Italy is therefore 1:908. The remaining infants presented a subclinical hypothyroidism (21.25%) or a complete normal serum thyroid function (21.25%). These data could be drawn only from a retesting strategy of neonatal screening. Conclusions Our report describes the incidence of CH with delayed TSH rise in North-Eastern Italy and differentiates this clinical condition from other thyroid dysfunctions of preterm or LBW newborns. The second-screening strategy for CH in neonates with BW < 2500 g proved useful in detecting newborns who otherwise would not be identified at the first screening.



2016 ◽  
Vol 24 (10) ◽  
pp. 1424-1429 ◽  
Author(s):  
Rachel C Wiltink ◽  
Michelle E Kruijshaar ◽  
Rick van Minkelen ◽  
Willem Onkenhout ◽  
Frans W Verheijen ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document